Cargando…

HTLV-1 Tax induces Th1 master regulator T-bet and thus IFN-γ in CD4+CCR4+ T-cells of virus-associated myelopathy patients

Detalles Bibliográficos
Autores principales:	Araya, Natsumi, Sato, Tomoo, Tomaru, Utano, Coler-Reilly, Ariella, Yagishita, Naoko, Yamauchi, Junji, Hasegawa, Atsuhiko, Kannagi, Mari, Akiyama, Hisanao, Hasegawa, Yasuhiro, Takahashi, Katsunori, Kunitomo, Yasuo, Tanaka, Yuetsu, Utsunomiya, Atae, Jacobson, Steven, Yamano, Yoshihisa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4578109/ http://dx.doi.org/10.1186/1742-4690-12-S1-P44

Ejemplares similares

The plasticity of HTLV-1 infected CD4+CD25+CCR4+ T-cells through HTLV-1 tax in HAM/TSP
por: Araya, Natsumi, et al.
Publicado: (2011)

Humanized anti CCR4 antibody KW0761 targets HTLV-1 infected CD4+ CCR4+ and CD8+CCR4+ T cells to treat HAM/TSP
por: Yamano, Yoshihisa, et al.
Publicado: (2015)

CXCL10 and neopterin in CSF are candidate prognostic biomarkers for HTLV-1-associated myelopathy/tropical spastic paraparesis
por: Yamano, Yoshihisa, et al.
Publicado: (2014)

Human T-Lymphotropic Virus Type 1 (HTLV-1) and Regulatory T Cells in HTLV-1-Associated Neuroinflammatory Disease
por: Araya, Natsumi, et al.
Publicado: (2011)

Virus-induced CXCL10-CXCR3 positive feedback loop via astrocytes is critical for maintaining chronic inflammatory lesions in HAM/TSP
por: Sato, Tomoo, et al.
Publicado: (2014)

CSF CXCL10, CXCL9, and Neopterin as Candidate Prognostic Biomarkers for HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis
por: Sato, Tomoo, et al.
Publicado: (2013)

Potential role of HTLV-1 Tax-specific cytotoxic t lymphocytes expressing a unique t-cell receptor to promote inflammation of the central nervous system in myelopathy associated with HTLV-1
por: Tanaka, Yukie, et al.
Publicado: (2022)

Proposal of Classification Criteria for HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis Disease Activity
por: Sato, Tomoo, et al.
Publicado: (2018)

Interferon-α (IFN-α) suppresses HTLV-1 gene expression and cell cycling, while IFN-α combined with zidovudin induces p53 signaling and apoptosis in HTLV-1-infected cells
por: Kinpara, Shuichi, et al.
Publicado: (2013)

Functional impairment of Tax-specific but not CMV-specific CTLs in a minor population of asymptomatic HTLV-1-carriers
por: Hasegawa, Atsuhiko, et al.
Publicado: (2011)

Real-world clinical course of HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Japan
por: Tsutsumi, Shuntaro, et al.
Publicado: (2019)

The roles of innate and acquired immune responses on HTLV-I infection
por: Kannagi, Mari, et al.
Publicado: (2011)

Cerebrospinal Fluid CXCL10 as a Candidate Surrogate Marker for HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis
por: Tamaki, Keiko, et al.
Publicado: (2019)

IFN-α suppresses HTLV-1 expression via PKR in infected cells and renders them susceptible to AZT through p53 activation in AZT/IFN-α treatment
por: Kinpara, Shuichi, et al.
Publicado: (2014)

Proteomic profiling of HTLV-1 infected T-cells for the identification of potential biomarkers and therapeutic targets for HTLV-1 associated myelopathy/ tropical spastic paraparesis and adult T-cell leukemia
por: Ueda, Koji, et al.
Publicado: (2011)

EZH1/2 dual inhibitors suppress HTLV-1-infected cell proliferation and hyperimmune response in HTLV-1-associated myelopathy
por: Koseki, Akihito, et al.
Publicado: (2023)

Possibility of γδ T cell immunotherapy for HTLV-1-infected individuals
por: Sato, Tomoo, et al.
Publicado: (2011)

Abnormally High Levels of Virus-Infected IFN-γ(+)CCR4(+)CD4(+)CD25(+) T Cells in a Retrovirus-Associated Neuroinflammatory Disorder
por: Yamano, Yoshihisa, et al.
Publicado: (2009)

Impact of host immunity on HTLV-1 pathogenesis: potential of Tax-targeted immunotherapy against ATL
por: Kannagi, Mari, et al.
Publicado: (2019)

HAM-net national patient registration system reveals details of how Japanese patients with HTLV-1-associated myelopathy/tropical spastic paraparesis progress over time
por: Coler-Reilly, Ariella, et al.
Publicado: (2015)

Nation-wide epidemiological study in Japan on HTLV-1 associated myelopathy/tropical spastic paraparesis using HAM-net, a novel patient registration system
por: Coler-Reilly, Ariella LG, et al.
Publicado: (2014)

Mortality and risk of progression to adult T cell leukemia/lymphoma in HTLV-1–associated myelopathy/tropical spastic paraparesis
por: Nagasaka, Misako, et al.
Publicado: (2020)

Augmentation of donor-derived Tax-specific CTL responses by a novel Tax epitope-specific CD4+ helper T-cells in ATL patients after allogeneic hematopoietic stem cell transplantation
por: Hasegawa, Atsuhiko, et al.
Publicado: (2014)

Increased Expression of Human T Lymphocyte Virus Type I (HTLV-I) Tax11-19 Peptide–Human Histocompatibility Leukocyte Antigen A*201 Complexes on CD4(+) CD25(+)T Cells Detected by Peptide-specific, Major Histocompatibility Complex–restricted Antibodies in Patients with HTLV-I–associated Neurologic Disease
por: Yamano, Yoshihisa, et al.
Publicado: (2004)

Efficacy of Corticosteroid Therapy for HTLV-1-Associated Myelopathy: A Randomized Controlled Trial (HAMLET-P)
por: Yamauchi, Junji, et al.
Publicado: (2022)

Creation and validation of a bladder dysfunction symptom score for HTLV-1-associated myelopathy/tropical spastic paraparesis
por: Yamakawa, Natsuko, et al.
Publicado: (2020)

SUV39H1 interacts with HTLV-1 Tax and abrogates Tax transactivation of HTLV-1 LTR
por: Kamoi, Koju, et al.
Publicado: (2006)

Characteristics of HAM/TSP after kidney transplantation from HTLV-1 positive living donors
por: Kimura, Miyuna, et al.
Publicado: (2015)

Short‐term cultured autologous peripheral blood mononuclear cells as a potential immunogen to activate Tax‐specific CTL response in adult T‐cell leukemia patients
por: Ishizawa, Miku, et al.
Publicado: (2021)

The roles of acquired and innate immunity in human T-cell leukemia virus type 1-mediated diseases
por: Kannagi, Mari, et al.
Publicado: (2012)

IL-10-mediated signals act as a switch for lymphoproliferation in Human T-cell leukemia virus type-1 infection by activating the STAT3 and IRF4 pathways
por: Sawada, Leila, et al.
Publicado: (2017)

Clinical subtype of HAM/TSP based on clinical course and laboratory findings
por: Yamano, Yoshihisa, et al.
Publicado: (2011)

Functional impairment of Tax-specific but not cytomegalovirus-specific CD8(+ )T lymphocytes in a minor population of asymptomatic human T-cell leukemia virus type 1-carriers
por: Takamori, Ayako, et al.
Publicado: (2011)

Nation-wide epidemiological study of Japanese patients with rare viral myelopathy using novel registration system (HAM-net)
por: Coler-Reilly, Ariella L. G., et al.
Publicado: (2016)

Reduced Tim-3 expression on HTLV-I Tax-specific cytotoxic T lymphocytes in HTLV-I infection
por: Abdelbary, Nashwa H, et al.
Publicado: (2011)

Identification of a novel motif responsible for the distinctive transforming activity of human T-cell leukemia virus (HTLV) type 1 Tax1 protein from HTLV-2 Tax2
por: Shoji, Toshiyuki, et al.
Publicado: (2009)

HTLV-1 modulates the frequency and phenotype of FoxP3(+)CD4(+) T cells in virus-infected individuals
por: Satou, Yorifumi, et al.
Publicado: (2012)

The HTLV-1 Tax interactome
por: Boxus, Mathieu, et al.
Publicado: (2008)

M-Sec induced by HTLV-1 mediates an efficient viral transmission
por: Hiyoshi, Masateru, et al.
Publicado: (2021)

The phase-I study of a therapeutic vaccine to ATL patients with autologous dendritic cells pulsed with peptides corresponding to Tax-specific CTL epitopes
por: Suehiro, Youko, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_12f703ieqba6e5bi6f7c5qc0ps